Clinuvel Pharmaceuticals Ltd ADR (CLVLY PINK) stock market data APIs

$6.9523 0(0%)
as of June 16, 2025
Try our APIs with free plan!

Clinuvel Pharmaceuticals Ltd ADR Financial Data Overview

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900 and Parvysmelanotide (VLRX001), both alpha-melanocyte stimulating hormone analogue; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. It is also developing NEURACTHEL (ACTH), an adrenocorticotropic hormone to produce cortisol and enables the combat of stress and regulation of immune responses, maintenance of blood pressure, moderation of blood sugar, and regulation of metabolism. The company was incorporated in 1999 and is headquartered in Melbourne, Australia.

Prev. Close 6.9523
Open 6.9523
High 6.9523
Low 6.9523
52 wk Range 6-11.3602
Market Cap 349 M
P/E Ratio 13.92
Shares Outstanding 50 124 K
Revenue 91 025 K
EPS 0.1338
Dividends (Yield) 0.0049
Beta 0.773

Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Clinuvel Pharmaceuticals Ltd ADR data using free add-ons & libraries


Get Clinuvel Pharmaceuticals Ltd ADR Fundamental Data

Clinuvel Pharmaceuticals Ltd ADR Fundamental data includes:

  • Net Revenue: 91 025 K
  • EBITDA: 51 728 K
  • Earnings Per Share: 0
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Clinuvel Pharmaceuticals Ltd ADR Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2021-06-30
  • EPS/Forecast: 0
GET THE PACKAGE

Get Clinuvel Pharmaceuticals Ltd ADR End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Clinuvel Pharmaceuticals Ltd ADR News

Get Apple Inc fresh news feed via Financial News API

Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat